Imaging of Vitreous Opacities in a Canadian Population

The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Floaters Vitreous Opacities vitreous floaters

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alberta Retina Consultants

Edmonton, Alberta, T5H 0X5, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged 18 years or older
Symptomatic vitreous opacities (floaters) in vision
Clear ocular media, to allow a clear view of the vitreous for the SVO-ID

Exclusion criteria

Younger than 18 years of age
Presence of vitreous hemorrhage
Cataract Grade 3 and above
Opacification of lens, cornea, or vitreous
Diagnosis of narrow angle glaucoma
Refractive error is outside the range of -6D to+3D
Astigmatism is outside the range of +/-2D of cylinder

Treatment and study plan

SVO-ID

Device

Combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for imaging of the eye

Primary outcomes

Successful capture of SLO and OCT imaging data of SVOs for algorithm development

Time frame: Through study completion, an average of 6-8 months

Successful collection of SLO and OCT imaging data

Secondary outcomes

Collection of patient-reported symptoms

Time frame: Through study completion, an average of 6-8 months

Patient feedback regarding symptoms related to SVOs being imaged

Sponsors and collaborators

Lead sponsor

PulseMedica

Industry

Registry information

Official study title

Acquisition of Imaging Data of Vitreous Opacities in Human Eyes Using a Non-Invasive Imaging Device

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Jan 12, 2024
Registry last updated: Sep 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed